site-logo
  • LiquidHALLMARK®
  • Resources
    • Publications
    • News & Events
  • Patients
  • Company
    • About Us
    • News & Events
    • Careers
    • Contact Us
  • Portal Login

Your cancer is unique.

Cancer is a disease caused by genomic changes in the cells of our body. These changes, called mutations, can be harmful, beneficial, or have no effect. Harmful mutations can cause normal cells to grow and divide uncontrollably, leading to cancer.

Genomic profiling sheds light on the combination of mutations that makes each patient’s cancer unique. This information can be used to personalize treatment for every patient.

Stocksy
scroll-arrow
liquid-hallmark-bg

LiquidHALLMARK® provides Swift , Simple and Sensitive Genomic Profiling

Genomic testing provides additional information to your provider that helps to personalize treatment according to your tumor’s genomic profile. Your genomic profile can also be used to match you to suitable clinical trials where new medicines are being developed, as well as track mutation changes in your tumor.

LiquidHALLMARK is a liquid biopsy genomic test that reveals important information about a tumor from a single blood draw. This information is what is known as a tumor’s genomic profile. LiquidHALLMARK provides your doctor with information to develop a personalized treatment plan at the time of diagnosis based on your tumor genomic profile. Testing can also be utilized to monitor your treatment response and/or changes within a tumor.

What should you expect?

  1. Talk to your provider about getting tested.
  2. Your provider can order LiquidHALLMARK and send a blood sample for testing.
  3. LiquidHALLMARK detects cancer-driving gene mutations from your blood sample.
  4. A personalized report is sent to your provider in ~7 days.
  5. Your provider will contact you to discuss the results and next steps in your care.

 

View Patient Information

Billing

LiquidHALLMARK® is covered for most Medicare and commercial healthcare plans when clinical criteria is met.

Lucence is committed to making sure that cost is not a barrier for patients to access LiquidHALLMARK® liquid biopsy testing.

For billing questions or financial assistance, please contact a Lucence Reimbursement Advisor

  • Email: [email protected].
  • Phone: 888-582-3623, x516
    (Monday-Friday, 8:00am to 5:00pm PST)

*For US Residents Only

View Billing FAQs
liquik-image1

Up arrow Back to top
Footer logo
Reach Us
3520 W Bayshore Road, Palo Alto, CA 94303 [email protected] (888) 582 3623
Subscribe for Updates

    Follow Us
    • facebook facebook-white
    • linkedin linkedin-white
    • twitter twitter-white

    © 2023 Lucence Health Inc. All rights reserved. All logos and trademarks are the property of Lucence or their respective owners.

    LiquidHALLMARK® | AmpliMark™ | Publications| Careers | About | Privacy

    Lucence secures approval for its Singapore-invented cancer tests from Medicare

    >